[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings Inc (ORGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 231,615
  • Shares Outstanding, K 128,675
  • Annual Sales, $ 564,170 K
  • Annual Income, $ 37,030 K
  • EBIT $ -36 M
  • EBITDA $ -9 M
  • 60-Month Beta 1.34
  • Price/Sales 0.42
  • Price/Cash Flow 2.84
  • Price/Book 1.60

Options Overview Details

View History
  • Implied Volatility 100.63% (+12.82%)
  • Historical Volatility 93.50%
  • IV Percentile 7%
  • IV Rank 2.80%
  • IV High 1,264.54% on 08/07/26
  • IV Low 67.05% on 05/15/26
  • Expected Move (DTE 26) 0.0000 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 28
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 869
  • Open Int (30-Day) 677
  • Expected Range 1.8000 to 1.8000

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.09
  • Growth Rate Est. (year over year) +1,110,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5400 +16.88%
on 08/07/26
2.6750 -32.71%
on 07/22/26
-0.8800 (-32.84%)
since 07/21/26
3-Month
1.5400 +16.88%
on 08/07/26
2.7193 -33.81%
on 05/27/26
-0.8600 (-32.33%)
since 05/21/26
52-Week
1.5400 +16.88%
on 08/07/26
7.0771 -74.57%
on 11/11/25
-2.6700 (-59.73%)
since 08/21/25

Most Recent Stories

More News
Organogenesis: Q2 Earnings Snapshot

Organogenesis: Q2 Earnings Snapshot

ORGO : 1.8000 (-2.17%)
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results

CANTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development,...

ORGO : 1.8000 (-2.17%)
Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers

CANTON, Mass., July 27, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on product solutions for the Advanced Wound Care and Surgical...

ORGO : 1.8000 (-2.17%)
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026

CANTON, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development,...

ORGO : 1.8000 (-2.17%)
Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis

CANTON, Mass., July 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on product solutions for the Advanced Wound Care and Surgical...

ORGO : 1.8000 (-2.17%)
Organogenesis Q1 Earnings Call Highlights

Organogenesis (NASDAQ:ORGO) reported a sharp year-over-year revenue decline in the first quarter of 2026, with executives pointing to significant disruption in the skin substitute market following Medicare...

ORGO : 1.8000 (-2.17%)
Organogenesis: Q1 Earnings Snapshot

Organogenesis: Q1 Earnings Snapshot

ORGO : 1.8000 (-2.17%)
Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results

CANTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development,...

ORGO : 1.8000 (-2.17%)
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®

CANTON, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...

ORGO : 1.8000 (-2.17%)
Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM

Statistically significant (p

ORGO : 1.8000 (-2.17%)

Business Summary

Organogenesis is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

See More

Key Turning Points

3rd Resistance Point 1.9433
2nd Resistance Point 1.9067
1st Resistance Point 1.8533
Last Price 1.8000
1st Support Level 1.7633
2nd Support Level 1.7267
3rd Support Level 1.6733

See More

52-Week High 7.0771
Fibonacci 61.8% 4.9619
Fibonacci 50% 4.3085
Fibonacci 38.2% 3.6552
Last Price 1.8000
52-Week Low 1.5400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.